Hip joint diseases
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients who are candidate for THA with OCM approach 2. Patients who are expected to be followed up for at least 6 months postoperatively 3. Patients who are deemed to use the following device/implants (To eliminate evaluation bias due to device/implant model): AR Hip Navigation (Surgical navigation), G7 Cup (Acetabular cup), Vivacit-E Liner (Acetabular liner), Delta Ceramic Head with over 32 mm outside diameter (Femoral head), Avenir Complete Stem (Femoral stem) 4. Patients who are deemed to use the following tool (To eliminate evaluation bias due to tool model): Steri-Strip, Mepilex (Wound dressing)
Exclusion criteria
Exclusion criteria: 1. Patients who do not meet any of the inclusion criteria listed in 4-3-1 2. Patients with have skin diseases 3. Patients with dislocation hip 4. Patients with history of hip surgery(ies) 5. Patients who are eligible Cases a cup with 44 mm diameter or less is appropriate 6. Patients who have took THA for contralateral hip, or scheduled bilateral THA
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Wound healing (Difference between groups in scar assessment scores (POSAS, JSW Scar Scale) at 12 months postoperatively) | — |
Secondary
| Measure | Time frame |
|---|---|
| Wound healing (Difference between groups in scar assessment scores (POSAS, JSW Scar Scale) at 3 months postoperatively and 6 months), psychological impact of wound healing (MPIS), difficulty of each skin incision (Operative time, Implant alignment), clinical assessment scores (JOA, HHS, JHEQ, FJS-12), complications, length of skin incision, necessity of additional skin incision, and effect of switching to transverse incision based on surgeon's experience with OCM approach | — |
Countries
Japan
Contacts
University of Occupational and Environmental Health Department of Orthopaedic Surgery